SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Dispatches from AAPS

Bend Research hunting new partnerships to boost bioavailability offering

By Natalie Morrison , 17-Oct-2012
Last updated on 17-Oct-2012 at 15:39 GMT

Bend Research hunting new partnerships
Bend Research hunting new partnerships
Loading...

Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

Speaking to Outsourcing-Pharma.com at this week’s AAPS in Chicago, senior VP David Lyon said the partnership – over spray drying development – was the result of client demand for more services for their poorly soluble compounds.

And with the industry crying out for bioavailability solutions thanks to an uptick in novel biological targets, Lyon said more partnerships will be the way to offer a wider range of services.

“We’re a small company and we have some core competence we try to get as much out of as we can,” he told us.

“The industry as a whole is experiencing an increase in poorly soluble compounds and really that has to do with an increase of novel biological targets,” he added, and admitted, “We recognise we can’t be all things to all people.”

Lyonsaid partnerships will come both in the research and the manufacturing space.

However for Dow, the latest alliance will remain the key focus in the near future.

Senior research and development (R&D) manager Karen Coppens said: “At this point our strategy is to work with Bend Research on the spray dried applications.”

She added however: “If there are other options that make sense we will consider those but for right now we are partnered with bend research.”

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

A bitter pill to swallow: young people dislike tablets more than old

A bitter pill to swallow: young people dislike tablets more than old

Thomas Hein

Director, Sales & Business Development, Hermes

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Cobra Biologics talks recent fill finish acquisition and future growth plans

Cobra Biologics talks recent fill finish acquisition and future growth plans

Philip Ridley-smith

Business Development & Marketing Manager, Cobra Biologics

Catalent says sharing with industry will not dull competetive edge

Catalent says sharing with industry will not dull competetive edge

Kurt Nielsen and Cornell Stamoran

Various, Catalent

Bend Research hunting new partnerships to boost bioavailability offering

Bend Research hunting new partnerships to boost bioavailability offering

David Lyon and Karen Coppens

Various, Bend Research and Dow

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Andrea Schiefer

VP of European clinical operations and executive director of pharmacovigilance,...

Consolidation prevalent in industry, says third largest CMO

Consolidation prevalent in industry, says third largest CMO

Brad Carlson

VP Marketing 7 Sales, Aenova

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Aileen Ruff

Global Strategic Marketing Director, Biologics and Sterile Technologies at Catalent...

Kemwell Talks Expansion and Approvals in India and the US

Kemwell Talks Expansion and Approvals in India and the US

Christian Ahlmark

Director of Corporate Development , Kemwell Biopharma

AMRI Exec Discusses 'New Bar' in FDA Enforcement

Following the completion of remediation efforts to deal with an FDA warning letter, Chris...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Aesica says academic partnerships are key for CMOs

Aesica says academic partnerships are key for CMOs

Alan Raymond

Sales & Marketing Director, Aesica Pharmaceuticals

Wockhardt targets CMO space for diversification

Wockhardt targets CMO space for diversification

Tom Salus

Associate Vice President, Business Development - Contract Services, Wockhardt

Kemwell and Boehringer set to finish biologics plant in India

Kemwell and Boehringer set to finish biologics plant in India

Christian Ahlmark

Director of corporate development , Kemwell